therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-generic

Outcomes

01
biomarker-neutrophil-engraftment-time-to-days-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
02
biomarker-platelet-engraftment-time-days-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
03
immune-gvhd-acute-grade-2-to-4-cumulative-incidence-proportion-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
04
immune-gvhd-acute-grade-3-to-4-cumulative-incidence-proportion-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
05
immune-gvhd-chronic-cumulative-incidence-proportion-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
06
oncology-relapse-cumulative-incidence-percent-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
07
survival-gvhd-free-relapse-free-probability-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
08
survival-overall-proportion-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
09
survival-progression-free-proportion-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
10
survival-treatment-related-mortality-cumulative-incidence-proportion-cohort-measured
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival

therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-generic

Outcomes

biomarker-neutrophil-engraftment-time-to-days-measured

biomarker-platelet-engraftment-time-days-measured

immune-gvhd-acute-grade-2-to-4-cumulative-incidence-proportion-cohort-measured

immune-gvhd-acute-grade-3-to-4-cumulative-incidence-proportion-cohort-measured

immune-gvhd-chronic-cumulative-incidence-proportion-cohort-measured

oncology-relapse-cumulative-incidence-percent-cohort-measured

survival-gvhd-free-relapse-free-probability-cohort-measured

survival-overall-proportion-cohort-measured

survival-progression-free-proportion-cohort-measured

survival-treatment-related-mortality-cumulative-incidence-proportion-cohort-measured